News

FDASIA strengthens paediatric drug development and safety

FDASIA strengthens paediatric drug development and safety

The Food and Drug Administration Safety and Innovation Act (FDASIA), signed into law on July 9, 2012, renews and strengthens the improvement of safety and effectiveness of paediatric drugs, biological products, and medical devices used in children. It gives FDA the...

read more...
InNerMeD-I: advancing knowledge on neurometabolic diseases

InNerMeD-I: advancing knowledge on neurometabolic diseases

The Executive Agency for Health and Consumers (EAHC) has approved the project “Inherited NeuRoMetabolic Diseases INFORMATION NETWORK” (InNerMeD-I-network) of which the Gianni Benzi Foundation is a partner. NeuroMetabolic Diseases (NMDs) are genetic metabolic disorders...

read more...
Fondazione Benzi Awards 20 grants for training

Fondazione Benzi Awards 20 grants for training

Fondazione Gianni Benzi announces that 20 Grants have been assigned to graduate master and PhD students who responded to the Grant Announcement published in the framework of the V Foresight Training Course (Warsaw, September 29th – 30th 2012). Following the great...

read more...
The ‘medicine of gender’

The ‘medicine of gender’

The Montecitorio’s hall has approved the unitary motion about the ‘medicine of gender' requiring the Government will carry out concrete actions in the field of the gender medicine, including - the progress of medical, scientific and pharmacological research; - the...

read more...
The fight against doping: science, ethics, and education

The fight against doping: science, ethics, and education

Among the institutional tasks of Fondazione Gianni Benzi there is the promotion of the ethical and safe use of drugs, supporting studies on risk factors linked to particular categories of drugs and promoting transparent and scientifically adequate information. On the...

read more...